The network point-of-care glucose testing market size is expected to reach USD 2,109.01 million by 2034, according to a new study by Polaris Market Research. The report “Network Point-of-Care Glucose Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, and CareSens Expert Plus), Modality, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Network point-of-care glucose testing refers to a system of connected glucose monitoring devices that enable real-time data sharing between patients and healthcare providers through cloud-based platforms or electronic health records (EHRs). The network point-of-care glucose testing market growth is attributed to the rising prevalence of diabetes, increasing demand for real-time monitoring, and advancements in digital healthcare integration.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/network-point-of-care-glucose-testing-market/request-for-sample
A few key drivers propelling the network point-of-care glucose testing market demand are the rising adoption of continuous glucose monitoring (CGM) systems, technological innovations in wearable and handheld devices, and the need for remote patient management. Opportunities lie in emerging markets where diabetes cases are increasing, alongside the expansion of AI-driven analytics for predictive glucose monitoring. Trends such as noninvasive glucose testing, integration with mobile applications, and regulatory support for digital health solutions further support market expansion.
By Product Outlook (Revenue – USD Million, 2020–2034)
By Modality Outlook (Revenue – USD Million, 2020–2034)
By Regional Outlook (Revenue – USD Million, 2020–2034)